Vyriad's Incubator/Accelerator Round

Vyriad raised a round of funding on April 13, 2017. Investors include Mayo Clinic Business Accelerator.

Vyriad is a clinical-stage biotechnology company developing novel oncolytic virus therapies for the treatment of cancers that have significant unmet need. Vyriad's oncolytic immunovirotherapy products…

Articles about Vyriad's Incubator/Accelerator Round: